| Metric | შპს სისხლის ბანკი | შპს გენომიქსი | შპს სენამედ-პლიუსი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾1.4m₾3.1m | ₾1.3m₾1.5m | ₾1.2m₾1.0m |
| Revenue growth | -55.1% | -13.2% | 18.3% |
| Profitability | |||
| EBITDA | ₾29k₾475k | -₾304k-₾249k | ₾77k-₾42k |
| EBITDA margin | 2.1%15.1% | -22.9%-16.3% | 6.3%-4.1% |
| Net profit | -₾33k₾317k | -₾277k-₾149k | |
| ₾77k-₾42k |
| Net margin | -2.3%10.1% | -20.9%-9.8% | 6.3%-4.1% |
| Balance sheet | |||
| Total assets | ₾1.9m₾2.7m | ₾2.6m₾2.9m | ₾1.8m₾1.6m |
| Total equity | ₾1.8m₾2.7m | ₾1.2m₾1.5m | ₾1.5m₾1.4m |
| ROE | -1.8%11.8% | -23.2%-10.1% | 5.1%-2.9% |